WHO ICTRP trial
Relapse prevention in children and adolescents with DSM-IV Conduct Disorder…
EUCTR2010-021884-34-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-021884-34-NL |
|---|---|
| Public title | Relapse prevention in children and adolescents with DSM-IV Conduct Disorder treated with Risperidone: a Randomized Double blind, Placebo-Controlled, Discontinuation Study. - CONCA-2 |
| Scientific title | Relapse prevention in children and adolescents with DSM-IV Conduct Disorder treated with Risperidone: a Randomized Double blind, Placebo-Controlled, Discontinuation Study. - CONCA-2 |
| Primary sponsor | Radboud University Medical Centre Nijmegen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Spain;Germany;Netherlands |
| Conditions | Conduct Disorder DSM-IV-TR; 312.8x, APA 2000 MedDRA version: 14.1 Level: PT Classification code 10064478 Term: Conduct disorder System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F]… |
| Interventions | Trade Name: Risperidone Product Name: Risperidone Product Code: 6000803 Pharmaceutical Form: Tablet INN or Proposed INN: Risperidone CAS Number: 106266-06-2 Current Sponsor code: CHMP/384877/2008 Other descriptive name: RISPERIDONE… |
| Registration date | Apr 17, 2012 |
| Target size | 200 |
| Secondary IDs | PERS3 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: